Forecast

Buy	0
Hold	1
Sell	0

News Go to news feed

AMS shareholders approve takeover by H.B. Fuller

AMS shareholders have approved the planned cash takeover by H.B. Fuller, a milestone since the announcement on 25 June 2026. H.B. Fuller expects the transaction to close by the end of the year, subject to further regulatory approvals and contractual conditions. The company says the combination of AMS medical technologies and H.B. Fuller’s global reach should enable growth, higher margins and a stronger healthcare platform. » More on de.investing.com
TA Associates will not make takeover offer for AMS

TA Associates has confirmed it does not intend to make an offer for the entire issued and to‑be‑issued share capital of AMS. The decision follows earlier reviews of a possible offer and was disclosed under Rule 2.8 of the City Code on Takeovers and Mergers. TA Associates reserves the right, in certain circumstances, to lift the Takeover Panel’s restrictions. » More on de.investing.com
AMS increases revenue in 2025 by 29% and raises dividend by 10%

AMS reports preliminary 2025 revenue growth of 29%, an adjusted EBITDA increase of 24% and adjusted diluted earnings per share up 12%. Adjusted EPS was £0.12 (unadjusted £0.05), and adjusted pre-tax profit was £33.90m versus £17.80m total. The board proposes a 10% increase in the annual dividend. For 2026 AMS expects revenue of £245.3m and adjusted EBITDA of £55.2m, supported by strong surgical businesses, a recovery in the woundcare segment and the full contribution of the acquisitions Peters Surgical and Syntacoll; several product approvals have been announced. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2017, AMS AG UNSPON.ADR/1/2 has already paid €0.0842 in dividends. The last payout was in June 2017.

Financials

In the last quarter, AMS AG UNSPON.ADR/1/2 had revenue of €805M and net profit of -€122M

(EUR)	Jun 2026	YoY
Revenue	805M	3.87%
Gross profit	207M	5.08%
Net profit	-122M	12,300.00%
EBITDA	170M	24.44%

Fundamentals

Metric	Value
Market capitalization	€3.79B
Number of shares	395.7M
52-week high/low	€13.03 - €3.62
Dividends	No
Beta	1.85
P/E ratio	-5.82
PEG ratio	0.07
P/B ratio	2.67
P/S ratio	0.57

Company profile

Die ams-OSRAM AG entwickelt, produziert und vertreibt LED- und optische Sensorlösungen in Europa, dem Mittleren Osten, Afrika, Nord- und Südamerika sowie im asiatisch-pazifischen Raum. Das Unternehmen ist in den Segmenten Halbleiter und Lampen & Systeme tätig. Das Segment Halbleiter bietet halbleiterbasierte Produkte und Lösungen wie LEDs, Laser, optische und Bildsensoren für den Automobil-, Verbraucher- und Industriemarkt. Das Segment Lampen & Systeme bietet Lampen und Beleuchtungssysteme an, wie z.B. Spektralsensorik, Umgebungsbeleuchtung und intelligente Beleuchtung, Gartenbaubeleuchtung, Lichtlaufzeitmessung, Anwesenheitserkennung, Nahinfrarot, menschengerechte Beleuchtung, Außen- und Innenbeleuchtungslösungen für den Automobil-, Industrie- und Medizinmarkt. Das Unternehmen war früher als ams AG bekannt und änderte seinen Namen im Januar 2022 in ams-OSRAM AG. ams-OSRAM AG wurde 1981 gegründet und hat seinen Hauptsitz in Premstätten, Österreich.